Announcement
18 Jun 2026
In June 2026, the Office of the United States Trade Representative announced the initiation of a Section 301 investigation into Germany's pricing policies and practices for innovative pharmaceutical products.
Source
Sign in to access
Number of interventions
1
0 certainly harmful
1 likely harmful
0 liberalising
List of interventions
Implementation date
No implementation date
Revocation date:
No revocation date
Announced: 18 Jun 2026
Import tariff
Recent update from 19 Jun 2026:
On 18 June 2026, the Office of the United States Trade Representative (USTR) announced the initiation of a Section 301 investigation into Germany's acts, policies, and practices related to the pric...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.